Cost-effectiveness of carbon ion radiation therapy for locally recurrent rectal cancer

Cancer Science

Volumn 101, Issue 8, 2010, Pages 1834-1839

  Mobaraki, Abdulelah ^a   Ohno, Tatsuya ^a   Yamada, Shigeru ^b   Sakurai, Hideyuki ^a   Nakano, Takashi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CARBON ION RADIATION THERAPY; CLINICAL ARTICLE; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTHERMIC THERAPY; MALE; MULTIMODALITY CANCER THERAPY; PRIMARY TUMOR; PRIORITY JOURNAL; RECTUM CARCINOMA; RECURRENT CANCER; RETROSPECTIVE STUDY; SKIN TOXICITY; TREATMENT DURATION;

AGED; CARBON; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HEAVY IONS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECTAL NEOPLASMS;

EID: 77954837185     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01604.x     Document Type: Article

References (36)

1. Parkin D, Bray F, Ferlay J. Global cancer statistics 2002. CA Cancer J Clin 2005, 55:74-108.
2. Ferlay J, Bray F, Pisani P. Globocan 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5 Version 2.0 2004, Lyon, France, IARC Press
3. Ohno Y, Nakamura T, Murata K. Prediction of cancer incidence in Japan. Cancer Statistic -2004 2004, 201-17. Oshima A, Kuroiwa T, Tajima K. In, eds, Tokyo, Shinohara Shuppan
4. Kobayashi A, Sugito M, Ito M. Predictors of successful salvage surgery for local pelvic recurrence of rectosigmoid colon and rectal cancers. Surg Today 2007, 37:853-9.
5. Bosanquet N, Sikora K. The economics of cancer care in the UK. Lancet Oncol 2004, 5:568-74.
6. National medical care expenditure trends in Japan (1977-2002). http://ganjoho.ncc.go.jp/public/statistics/backnumber/odjrh3000000h332-att/data16.pdf, [Cited 12 March 2009.] Available from URL:
7. Tsujii H, Kamada T, Baba M. Clinical advantages of carbon-ion radiotherapy. New J Phys 2008, 10:075009.
8. Herndon J, Hwang R, Bozic K. Healthcare technology and technology assessment. Eur Spine J 2007, 16:1293-302.
9. Jakel O, Land B, Combs S. On the cost-effectiveness of Carbon ion radiation therapy for skull base chordorna. Radiother Oncol 2007, 83:133-8.
10. Okamura S, Kobayashi R, Sakamaki T. Case-mix payment in Japanese medical care. Health Policy 2005, 74:282-6.
11. Yasunaga H, Ide H, Imamura T. Impact of the Japanese diagnosis procedure combination-based payment system on cardiovascular medicine-related costs. Int Heart J 2005, 46:855-66.
12. Asao T, Sakurai H, Harashima K. The synchronization of chemotherapy to circadian rhythms and irradiation in pre-operative chemoradiation therapy with hyperthermia for local advanced rectal cancer. Int J Hyperthermia 2006, 22:399-406.
13. Wildner M. Health economic issues of screening programmes. Eur J Pediatr 2003, 162:S5-7.
14. Tsujii H, Mizoe J, Kamada T. Clinical results of carbon ion radiotherapy at NIRS. J Radiat Res 2007, 48:A1-13.
15. Shibuya H, Tsujii H. The structural characteristics of radiation oncology in Japan in 2003. Int J Radiat Oncol Biol Phys 2005, 62:1472-6.
16. Tsujii H, Kamada T, Debus J. Overview of experience with heavier charged particle radiotherapy. Proton and Charged Particle Radiotherapy 2008, 123. Delaney TF, Kooy HM, In, eds, Philadelphia, PA, Lippincott Williams and Wilkins
17. Nakagawa Y, Yoshihara H, Kageji T. Cost analysis of radiotherapy, carbon ion therapy, proton therapy and BNCT in Japan. Appl Radiat Isot 2009, 67:S80-3.
18. Muramatsu M, Kitagawa A, Drentje AG. The compact electron cyclotron resonance ion source KeiGM for the carbon ion therapy facility at Gunma University. Rev Sci Instrum 2010, 81:3.
19. Meeting abstract "Current Status of Gunma University Heavy Ion Medical Center" http://www.egms.de/static/en/meetings/ptcog2009/09ptcog146.shtml, [Cited 21 March 2010.] Available from URL:
20. Brower V. Carbon ion therapy to debut in Europe. J Natl Cancer Inst 2009, 101(2):74-6.
21. Ando K, Kase Y. Biological characteristics of carbon-ion therapy. Int J Radiat Biol 2009, 85(9):715-28.
22. Morrison A. Carbon Ion Radiation Therapy [Environmental Scan issue 3]. 2009, http://www.cadth.ca/media/pdf/hta_Carbon-Ion-Radiation-Therapy_es-issue-3_e.pdf, Ottawa, Canadian Agency for Drugs and Technologies in Health (cadth), [Cited 22 March 2010.] Available from URL:
23. Jones B. Joint symposium 2009 on carbon ion radiotherapy. Br J Radiol 2009, 82:884-9.
24. Goitein M, Jermann M. The relative costs of proton and X-ray radiation therapy. Clin Oncol (R Coll Radiol) 2003, 15:S37-50.
25. Pommier P, Gueye N, Buron C. Medico-economic and Spatial Modelization for decision making in innovative therapies: application to light ions therapy projects in Europe. Radiother Oncol 2006, 81:S411.
26. Schulz-Ertner D, Haberer T, Scholz M. Acute radiation-induced toxicity of heavy ion radiotherapy delivered with intensity modulated pencil beam scanning in patients with base of skull tumors. Radiother Oncol 2002, 64:189-95.
27. Tveit K, Wiig J, Olsen D. Combined modality treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer. Radiother Oncol 1997, 44:277-82.
28. Knol H, Hanssens P, Rutten H. Effect of radiation therapy alone or in combination with surgery and/or chemotherapy on tumor and symptom control of recurrent rectal cancer. Strahlenther Onkol 1997, 173:43-9.
29. Valentini V, Morganti A, Gambacorta M. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase II study. Int J Radiat Oncol Biol Phys 2006, 64:1129-39.
30. Willett C, Shellito P, Tepper J. Intraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma. Cancer 1991, 67:1504-08.
31. Bussieres E, Gilly F, Rouanet P. Recurrences of rectal cancers: results of a multimodal approach with intraoperative radiation therapy. French group of intraoperative radiation therapy. Int J Radiat Oncol Biol Phys 1996, 34:49-56.
32. Valentini V, Morganti A, De Franco A. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma. Cancer 1999, 86:2612-24.
33. Wiig J, Poulsen J, Larsen S, Braendengen M, Waehre H, Giercksky K. Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer. Eur J Surg 2002, 168:42-8.
34. Bentzen SM. Randomized controlled trials in health technology assessment: overkill or overdue? Radiother Oncol 2008, 86:142-7.
35. Goitein M, Cox JD. Should randomized clinical trials be required for proton radiotherapy? J Clin Oncol 2008, 26:175-6.
36. Suit H, Kooy H, Trofimov A. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Radiother Oncol 2008, 86:148-53.